Recurrent metachronous metastatic multifocal renal cell carcinoma to the pancreas.
UT Health San Antonio creates innovative organoid for advancing understanding of pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC), a certain type of pancreatic cancer, is a ruthless killer with an average five-year survival rate of less than 10%. Most patients are diagnosed at a late stage when the cancer has already spread throughout their bodies. And the problem is only growing worse. By 2030, pancreatic cancer is expected […]
Meet Mays Cancer Center's newest providers
Mays Cancer Center continues to expand specialized cancer care with new providers bringing expertise in complex cancer surgery and reconstruction, gastrointestinal surgical oncology, lung and gastrointestinal cancers, lymphoma and other blood disorders and oncology nutrition. These additions strengthen the range of specialized services available to patients across South Texas.